BTC
$7986.6788
-1.40074%ETH
$172.4959
-2.88676%XRP
$0.2468
-2.43394%BCH
$239.2447
-1.48301%USDT
$1.0056
-0.887009%LTC
$52.932
-5.32042%EOS
$2.9942
-4.28909%BNB
$17.4375
-6.32974%BSV
$103.6965
-4.03997%XLM
$0.0625
-4.81774%TRX
$0.0158
-6.83953%ADA
$0.0394
-6.03976%XMR
$56.9585
-3.28213%LEO
$0.9582
-1.02086%LINK
$2.6355
-5.77639%NEO
$11.2952
-4.19923%XTZ
$1.205
-0.677387%HT
$3.2309
-5.0002%MIOTA
$0.2318
-5.36396%ATOM
$3.3165
-2.52233%Search Coins
$MTX from the X's family 100% on #huobi #HuobiGlobal What is the next X's to move on #huobi I will GO with $GNX
"Why not create a tool that makes it easier to visualize molecules, using computer graphics?" Read more (subscription required) @SDbusiness http://bit.ly/NanomeinBusinessJournal …
While #VR brings to mind a dystopic future for some, encountering the technology in daily life is becoming increasingly common. Some argue that VR could help humans more simply socialize. Learn more: http://bit.ly/VirtualRealityPastPresentFuture …
Researchers have illuminated the structure of over 122,000 proteins, stored on public databases such as @rcsbPDB. Structural biology research has led to new medical treatments for misshapen molecules. Learn more: http://bit.ly/StructuralBiologyMolecularModeling …
. @Veritasium modified aerogels to take advantage of their unique characteristics over on @YouTube. Check it out! #nanotechnology https://youtu.be/GcdB5bFwio4
ICYMI: Check out "Nanome of the Month: Silicon P-N Junction & Al Cr O Battery Cathode" on @YouTube today: http://bit.ly/SiliconNJunctionAlCrOBatteryCathode …
We are launching a NEW series, Nanome of the Month! What's a Nanome? It is the new unit of things at the nanoscale. Check out this month's Nanomes: https://www.youtube.com/watch?v=pXopycoaWXo …
#Diphtheria is an infection that can lead to difficulty breathing, heart failure, paralysis, and death. Here is a #VirtualReality rendering of the @rcsbPDB file for the #Crystal structure of diphtheria toxin mutant CRM197t.pic.twitter.com/duw6qAiYMi
Infliximab, popularly known as Remicade, is a prescription #Medication used to treat moderate to severe Crohn's Disease. You can see it here in #VirtualReality using Nanome's software. You simply open up a @rcsbPDB file in the software and explore.pic.twitter.com/ICrAUTAa6L
#Rivaroxaban (BAY 59-7939) is an oral Factor Xa inhibitor in clinical development. It is designed to treat thromboembolic disorders. Here you can see it displayed using the Nanome software in #virtualreality. Simply load in the @rcsbPDB file and explore.pic.twitter.com/bmQkvJ4MAw
Rituximab (Rituxan and MabThera) treats rheumatoid #arthritis that other medications failed to help. Here you can see its crystal structure in complex with an epitope peptide in #virtualreality via @rcsbPDB.pic.twitter.com/HkcxoARHqI
“I think the biggest innovations of the 21st century will be at the intersection of #biology and #technology. A new era is beginning.” — Steve Jobs...Check out our blog on biopharma: https://blog.matryx.ai/biopharmaceuticals-biotech-the-market-for-new-medical-innovation-1b0670d36a01 …
“Moving forward, a lot of the VR haters that complain about resolution, ergonomics and minor details will disappear,” wrote Nanome CEO @StevenMcCloskey. “We will see a lot less negativity in the VR industry.” https://blog.matryx.ai/virtual-reality-past-present-future-e0995ce386bf …
Experts were out in force @coindesk’s #Consensus2019 last week to talk about the state of #blockchain in #pharma. Read more: http://bit.ly/ConsensusBlockchainPharma …
When Sergei Skripal and daughter Yulia Skripal were poisoned in Salisbury, England on March 4, 2018, the British government accused Russia of attempted murder and expelled 23 Russian diplomats from the country. #Biodefense http://bit.ly/VRSoftwareNerveAgents …
ICYMI Everything you need to know about #VirtualReality Read more: http://bit.ly/VirtualRealityPFuture …
Drawing a 3D tetrahedral cage in VR using @nanome_inc . @Mechanophore @AnnaYang89 @tp_money2 full video: https://youtu.be/IME6eUmelO4 https://pubs.acs.org/doi/abs/10.1021/jacs.6b00468 …pic.twitter.com/5Z4x8nk8bW
#ThrowbackThursday - Until now, pharmaceutical companies have had to spend hundreds of millions of dollars a year on third-party timestamp services to document the discovery process of new potential medicines for FDA auditors and to protect their IP. http://bit.ly/MatryxMainnet
In the future: molecular #cannabis in #VirtualReality on the #blockchain. https://twitter.com/nanome_inc/status/1138474429057363968 …
Factor Xa in Complex with the Inhibitor #Apixaban, a blood thinner that reduces blood clotting and the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. #Medicinepic.twitter.com/DelJXISQKx
Making molecules in virtual reality. Triazolophane-anion complex @nanome_inc @amar_flood Full video: https://youtu.be/MqqQlY2VDkc pic.twitter.com/ocbJBa94Gq
Adalimumab, commonly known under the brand name #Humira by @abbvie, treats rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. Check it out in #VR:pic.twitter.com/4ASkHcQ3jb
Sulfonamides are an important part of medicines that treat allergies and cough symptoms and have antifungal and antimalarial functions. It is the molecular basis of many #drugs. Check it out in #VR.pic.twitter.com/SobXTCSmg0
CavAb structure in complex with amlodipine, which can treat high blood pressure and chest pain. Check out this #medicine in #VirtualRealitypic.twitter.com/LGLsWP7aq5
The crystal structure of human CYP3A4 bound to metformin, an anti-diabetic #medication, as seen in #virtualreality.pic.twitter.com/DdukUWkBJ4
Matryx(MTX)NewsLogin to watch
$0.02-3.27839%
Market: $565.7k
Matryx (MTX) is currently the #1023 cryptocurrency by market cap at $565.7k USD. Trading volume for Matryx over the last 24 hours is $29.3k USD. There have been no news stories on Matryx over the last 7 days. The most common news source covering Matryx is Matryx Twitter and the most common news category is Project Announcements.
